SciELO - Scientific Electronic Library Online

 
vol.145 número11Asociación entre variables demográficas y socioeconómicas y mortalidad por cirrosis y otras enfermedades del hígadoAtributos de las guías clínicas del régimen de garantías en salud relacionados con su adopción en la atención primaria: una evaluación en 3 centros de salud familiar índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Revista médica de Chile

versão impressa ISSN 0034-9887

Resumo

LADRON DE GUEVARA, David et al. Cáncer sincrónico y metacrónico detectado con PET/CT en población oncológica. Rev. méd. Chile [online]. 2017, vol.145, n.11, pp.1421-1428. ISSN 0034-9887.  http://dx.doi.org/10.4067/s0034-98872017001101421.

Background

Imaging with F18-fluorodeoxyglucose PET/CT is used to determine sites of abnormal glucose metabolism and can be used to characterize and localize many types of tumors.

Aim

To assess the prevalence of multiple primary malignant neoplasms (MPMN) detected by PET/CT in cancer patients.

Material and Methods

F18-fluorodeoxyglucose PET/CT scans performed to 800 patients with a newly diagnosed cancer or with already treated tumors were retrospectively reviewed. In patients whose examination described incidental findings not related to the primary tumor, a research was done about further laboratory, imaging or pathological studies.

Results

In 188 PET/CT scans (23%) an incidental finding was found. Of these, 66 (35%) were considered as MPMN, 12 as atypical metastases of a known primary tumor, 14 as false positive images (inflammatory or physiologic uptake) and 29 as benign or low grade tumors. In 67 cases (36% of all incidental tumors), the finding was not confirmed. Seven percent of patients with a newly diagnosed tumor had a synchronic MPMN detected by PET/CT. Nine percent of patients with treated tumors developed a metachronous MPMN during their follow up. The most common incidental tumors were thyroid cancer in 15 cases, kidney cancer in 13, lung cancer in 10, colorectal carcinoma in 9, breast cancer in 6, prostate cancer in 4, non-Hodgkin lymphoma in 3 and pancreatic cancer in 2.

Conclusions

A MPMN is detected by PET/CT in a significant number of cancer patients.

Palavras-chave : Neoplasms, Multiple Primary; Neoplasm, Second Primary; Positron-Emission Tomography.

        · texto em Espanhol     · Espanhol ( pdf )